CANCER TODAY provides a suite of data visualization tools to explore estimates of the incidence, mortality, and prevalence of 36 specific cancer types and of all cancer sites combined in 185 countries or territories of the world in 2020, by sex and age group, as part of the GLOBOCAN project...
IARC. Cancer today. Available: https://gco.iarc.fr/today/home Google Scholar 3. J. Ferlay, M. Colombet, I. Soerjomataram, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods http://www.ncbi.nlm.nih.gov/pubmed/30350310 Int J Cancer, 144 ...
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J. Clin., 68 (6) (2018), pp. 394-424 CrossrefGoogle Scholar [3] E. Dekker, P.J. Tanis, J. Vleugels, P.M. Kasi, M. Wallace Pure-amc Lancet, 394 (2019...
alpha-fetoprotein (AFP) is a well-established protein biomarker for hepatocellular carcinoma (HCC), and its core-fucosylated form AFP-L3 has been approved by FDA as a biomarker widely used in combination with the total AFP concentration for risk assessment of patients with chronic liver disease ...
Smart nanoparticles, which can respond to biological cues or be guided by them, are emerging as a promising drug delivery platform for precise cancer treatment. The field of oncology, nanotechnology, and biomedicine has witnessed rapid progress, leading
While strategies such as chemotherapy and immunotherapy have become the first-line standard therapies for patients with advanced or metastatic cancer, acquired resistance is still inevitable in most cases. The introduction of antibody‒drug conjugates
Cancer early detection and treatment response prediction continue to pose significant challenges. Cancer liquid biopsies focusing on detecting circulating tumor cells (CTCs) and DNA (ctDNA) have shown enormous potential due to their non-invasive nature a
Multimodal nanoparticles, utilizing quantum dots (QDs), mesoporous silica nanoparticles (MSNs), and gold nanoparticles (Au NPs), offer substantial potential as a smart and targeted drug delivery system for simultaneous cancer therapy and imaging. This me
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J. Clin., 71 (2021), pp. 209-249, 10.3322/caac.21660 Google Scholar [3] A. Tewabe, A. Abate, M. Tamrie, A. Seyfu, E. Abdela Siraj Targeted drug delivery...
According to Globocan (https://gco.iarc.fr/today/home (accessed on 16 December 2021)) in 2020, the estimated number of new cases reached almost 20 million, while the number of deaths was close to 10 million. Breast, colon, lung, and ovarian cancers are the most often diagnosed tumor ...